相关实验视频

Updated: Sep 10, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

通过细胞外ATP利用CD39抑制来增强抗瘤免疫力

Ke Jin¹, Rebecca Fuchs², Julie Clor¹

¹Department of Biology, Arcus Biosciences, Hayward, CA, United States.

Journal of immunology (Baltimore, Md. : 1950)

|August 24, 2025

概括

通过增强骨髓细胞激活和T细胞功能,抑制CD39可保护细胞外ATP (eATP) 并增强抗瘤免疫力. 这种方法有望通过调节瘤微环境来改善癌症疗法.

科学领域:

癌症学
免疫学
生物化学

背景情况:

CD39 (ENTPD1) 是调节细胞外核酸的一个关键酶.
它的抑制保持细胞外ATP (eATP) 和降低腺 (eADO),增强免疫反应.
CD39在酸性瘤微环境中表现出最佳活性,使其成为有前途的治疗点.

研究的目的:

研究CD39抑制在癌症中的治疗潜力.
阐明CD39抑制增强抗瘤免疫力的机制.
在人类细胞模型和真实瘤数据集中验证这些发现.

主要方法:

在癌症基因组图谱 (TCGA) 中对eATPase的RNA表达概况.
在不同pH值下对CD39活性进行酶性表征.
用CD39抑制剂和抗PD-1治疗的小鼠MC38瘤模型.
人类单细胞衍生的树突细胞/T细胞/癌细胞系共培养系统.
对人类瘤数据集的转录eATP签名生成和分析.

主要成果:

在固体瘤中,ENTPD1表现广泛.
CD39在pH值6. 8时表现出最大的催化活性.
在小鼠模型中,CD39抑制增强了骨髓细胞激活和瘤控制.
在人类的共同培养中,CD39抑制增加了IL-2,B大酶和IFNγ的产生.
在人类瘤中发现了一种新的转录性eATP特征.

结论:

通过增强eATP驱动的T细胞骨髓细胞激活, CD39抑制促进抗瘤免疫力.
这种机制在各种瘤类型和eATP生成条件中有效.
在瘤学中,CD39已被验证为增强抗瘤免疫反应的治疗标.

关键词:

抗体癌症树突细胞人类瘤免疫力

更多相关视频

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...